0HRT Stock Overview
CV Sciences, Inc. develops, manufactures, markets, and sells herbal supplements and hemp-based cannabidiol (CBD) in North America.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
CV Sciences, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.033 |
| 52 Week High | US$0.045 |
| 52 Week Low | US$0.033 |
| Beta | 0.63 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | -92.15% |
| 5 Year Change | n/a |
| Change since IPO | -94.74% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0HRT | GB Personal Products | GB Market | |
|---|---|---|---|
| 7D | 0% | 5.1% | 1.4% |
| 1Y | n/a | -6.5% | 1.1% |
Return vs Industry: Insufficient data to determine how 0HRT performed against the UK Personal Products industry.
Return vs Market: Insufficient data to determine how 0HRT performed against the UK Market.
Price Volatility
| 0HRT volatility | |
|---|---|
| 0HRT Average Weekly Movement | n/a |
| Personal Products Industry Average Movement | 6.4% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 11.3% |
| 10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: 0HRT has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 0HRT's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 43 | Joe Dowling | www.cvsciences.com |
CV Sciences, Inc. develops, manufactures, markets, and sells herbal supplements and hemp-based cannabidiol (CBD) in North America. It operates in two segments, Consumer Products and Specialty Pharmaceutical. The company offers its products under the PlusCBD, ProCBD, HappyLane, CVAcute, CVDefense, and PlusCBD Pet brands in the health care market sector, including nutraceutical, beauty care, specialty foods, and pet products through its websites, elect distributors, brick and mortar retailers, and select e-tailers.
CV Sciences, Inc. Fundamentals Summary
| 0HRT fundamental statistics | |
|---|---|
| Market cap | US$6.15m |
| Earnings (TTM) | US$3.10m |
| Revenue (TTM) | US$16.00m |
2.0x
P/E Ratio0.4x
P/S RatioIs 0HRT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0HRT income statement (TTM) | |
|---|---|
| Revenue | US$16.00m |
| Cost of Revenue | US$8.92m |
| Gross Profit | US$7.09m |
| Other Expenses | US$3.98m |
| Earnings | US$3.10m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.019 |
| Gross Margin | 44.27% |
| Net Profit Margin | 19.38% |
| Debt/Equity Ratio | 8.7% |
How did 0HRT perform over the long term?
See historical performance and comparison